GSK plc ADR diskutieren
GSK plc ADR
WKN: A3DMHS / Symbol: GSK / Name: GSK / Aktie / Pharmazeutika / Large Cap /
36,20 €
0,00 %
GSK plc (NYSE: GSK) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating on the stock.
Ratings data for GSK provided by MarketBeat
GSK plc (NYSE: GSK) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for GSK provided by MarketBeat
GSK plc (NYSE: GSK) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Ratings data for GSK provided by MarketBeat
GSK plc (NYSE: GSK) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating.
Ratings data for GSK provided by MarketBeat
GSK plc (NYSE: GSK) was upgraded by analysts at Berenberg Bank to a "strong-buy" rating.
Ratings data for GSK provided by MarketBeat
GSK plc (NYSE: GSK) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Ratings data for GSK provided by MarketBeat
GSK plc (NYSE: GSK) had its price target raised by analysts at Jefferies Financial Group Inc. from $52.50 to $53.00. They now have a "buy" rating on the stock.
Ratings data for GSK provided by MarketBeat
Neueste Beiträge
Tigress_Financial in Discuss Wal-Mart Stores Inc., Walmart Inc.